LONDON (Dow Jones)--ReGen Therapeutics PLC (RGT.LN), said Thursday that it has appointed Innovation China U.K. (ICUK) to assist in discussions with a major pharmaceutical company in China, which the company hopes will lead to the establishment of ReGen's business in this growing and important healthcare market. MAIN FACTS: -ICUK is a publicly funded programme established to support joint innovation and technology transfer between the U.K. and China. Shares closed Wednesday at 2.25 pence. -By Razak Musah Baba, Dow Jones Newswires; +44-20-7842-9275; razak.baba@dowjones.com (END) Dow Jones Newswires June 17, 2010 02:41 ET (06:41 GMT)